Last reviewed · How we verify
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis (APPLES)
This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were \< 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial.
Details
| Lead sponsor | LEO Pharma |
|---|---|
| Status | TERMINATED |
| Enrolment | 8071 |
| Start date | Wed May 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Jan 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Atopic Dermatitis
Countries
France, Netherlands, Austria, Ireland, United Kingdom, Germany, Poland, Canada, United States